A director proposes selling 2,000 Ligand (LGND) shares around November 12, 2026.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Ligand Pharmaceuticals Inc. director Martine Zimmermann has filed a notice proposing to sell 2,000 common shares of LGND, valued at approximately $636,336.20, around November 12, 2026. The filing also indicates that Zimmermann previously sold 1,200 common shares on September 10, 2026, for gross proceeds of $342,000.00.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.